Cantor Fitzgerald Weighs in on Kura Oncology FY2025 Earnings
Kura Oncology, Inc. (NASDAQ:KURA – Free Report) – Research analysts at Cantor Fitzgerald boosted their FY2025 earnings per share estimates for Kura Oncology in a research report issued on Wednesday, March 19th. Cantor Fitzgerald analyst L. Watsek now anticipates that the company will earn ($2.21) per share for the year, up from their prior estimate […]
